Portugal - engleski - HMA (Heads of Medicines Agencies)

pfizer limited - progesterone 1.38 g - vaginal device - cattle - progesterone

Rumunjska - engleski - HMA (Heads of Medicines Agencies)

pfizer limited - progesterone 1.38 g - vaginal device - cattle - progesterone

Slovenija - engleski - HMA (Heads of Medicines Agencies)

pfizer limited - progesterone 1.38 g - vaginal device - cattle - progesterone

Velika Britanija - engleski - HMA (Heads of Medicines Agencies)

pfizer limited - progesterone 1.38 g - vaginal device - cattle - progesterone

Izrael - engleski - Ministry of Health

merck serono ltd - progesterone - gel - progesterone 8 %w/w - progesterone - progesterone - treatment of infertility due to inadequete luteal phase. for use during in-vitro fertilisation, where infertility is mainly due to tubal idiopathic or endometriosis linked sterility associated with normal obulatory.

Izrael - engleski - Ministry of Health

ferring pharmaceuticals ltd - progesterone - vaginal tablets - progesterone 100 mg - progesterone - progesterone - progesterone supplementation or replacement in cases such as treatment of infertile women and ivf.

Izrael - engleski - Ministry of Health

cts ltd - progesterone micronized - capsules - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).

Izrael - engleski - Ministry of Health

cts ltd - progesterone - capsules - progesterone 100 mg - progesterone - progesterone - vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indications, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.

Irska - engleski - HPRA (Health Products Regulatory Authority)

merck serono limited - progesterone - vaginal gel - 8 %w/w - progestogens

Irska - engleski - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - progesterone - vaginal delivery system - 1.38 grams - progesterone - bovine - hormone